 |
|
Premature vascular and bone changes occur in COPD patients
June 18, 2007Researchers in the United Kingdom have found that patients with COPD, or chronic obstructive pulmonary disease, have greater arterial stiffness. The researchers also found that those COPD patients with osteoporosis, a common complication of the respiratory disease, had even greater arterial stiffness. These premature signs of aging may explain why COPD patients are at greater risk for cardiovascular disease.
Their research results appear in the second issue for June 2007 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society.
Dennis J. Shale, M.D., of the Department of Respiratory Medicine at Cardiff University in the United Kingdom, and eight associates studied 75 clinically stable COPD patients who had various levels of airway obstruction, and 42 smoker or ex-smoker control subjects who did not have cardiovascular disease or COPD.
COPD involves persistent obstruction of the airways caused by emphysema or chronic bronchitis. In most instances, both conditions result from years of smoking cigarettes. COPD is expected to become the third most common cause of death worldwide by 2020, according to the study authors.
Though the exact link between COPD and atherosclerosis was not identified by the researchers, they did find elevated levels of inflammation markers in those with COPD. Other research has demonstrated that inflammatory processes are involved in all stages of atherosclerosis, and there is also evidence that inflammation has a role in osteoporosis.
All participants in the U.K. study underwent spirometry to determine lung function, had their aortic pulse wave velocity measured along with another indirect measurement of arterial stiffness, took bone mineral density tests of their spine and hips, and had their blood sampled for inflammatory mediators.
"Increased arterial stiffness was present in patients with COPD over a wide range of severity of airway obstruction and was greatest in those with osteoporosis," said Dr. Shale. "Our findings indicate vascular changes predictive of cardiovascular disease occur and remain undetected in mild or early lung disease and may underlie the excess cardiovascular risk in COPD."
The researchers noted that age was an important factor influencing arterial stiffness, a problem that reflects the increasing rigidity of the aortic artery. The average age of the study cohort was 63.
"The increased arterial stiffness in patients within each decade is similar to changes seen in type I diabetes mellitus and suggest that age-related vascular changes occur prematurely in COPD, as compared with disease-free individuals," said Dr. Shale. "However, unlike diabetes mellitus, the risk of premature excess cardiovascular disease in COPD is not appreciated."
At the beginning of the study, none of the participants had a history of heart disease or possessed cardiovascular symptoms. Of the 75 COPD patients studied, 18 had osteoporosis, while among the controls, only two individuals suffered from abnormal loss of bony tissue. Also, those who had osteoporosis of the hip had a greater aortic pulse wave velocity than those without the hip problem.
In an editorial on the study in the same issue of the journal, Claus Vogelmeier, M.D., and Robert Bals, M.D., of Philipps-University, Marburg in Germany, said that the study provides "important new information" on the relationship of cardiovascular disease and COPD.
They noted that aortic pulse wave velocity-considered the most clinically relevant measure of arterial stiffness-has been shown to predict cardiovascular outcome in various populations. The authors also highlighted the study's correlation of pulse wave velocity and COPD severity as important.
"The more severe the flow limitation, the higher the pulse wave velocity values," wrote Drs. Vogelmeier and Bals. "Thus, COPD may induce arterial stiffness, which in turn may promote vascular remodeling, thickening of arterial walls and plaque formation. The process may start in the early stages of COPD and worsen with the decline of lung function."
The editorialists also commented on osteoporosis, which was the second focus of the study: "The authors found that bone mineral density was lower in patients with COPD than in control subjects. Among the patients with COPD, 32 percent had osteoporosis and this was not restricted to those with severe COPD."
Although the editorialists termed the relationship between COPD and osteoporosis in the study was not "novel," they noted that those patients with osteoporosis also had the greatest arterial stiffness values-a new finding.
They concluded that future research is necessary to uncover further relationships between this study's findings and accelerated aging processes in COPD, which might then be avoided.
American Thoracic Society
COPD involves persistent obstruction of the airways caused by emphysema or chronic bronchitis. In most instances, both conditions result from years of smoking cigarettes. COPD is expected to become the third most common cause of death worldwide by 2020, according to the study authors.
Though the exact link between COPD and atherosclerosis was not identified by the researchers, they did find elevated levels of inflammation markers in those with COPD. Other research has demonstrated that inflammatory processes are involved in all stages of atherosclerosis, and there is also evidence that inflammation has a role in osteoporosis.
All participants in the U.K. study underwent spirometry to determine lung function, had their aortic pulse wave velocity measured along with another indirect measurement of arterial stiffness, took bone mineral density tests of their spine and hips, and had their blood sampled for inflammatory mediators.
"Increased arterial stiffness was present in patients with COPD over a wide range of severity of airway obstruction and was greatest in those with osteoporosis," said Dr. Shale. "Our findings indicate vascular changes predictive of cardiovascular disease occur and remain undetected in mild or early lung disease and may underlie the excess cardiovascular risk in COPD."
The researchers noted that age was an important factor influencing arterial stiffness, a problem that reflects the increasing rigidity of the aortic artery. The average age of the study cohort was 63.
"The increased arterial stiffness in patients within each decade is similar to changes seen in type I diabetes mellitus and suggest that age-related vascular changes occur prematurely in COPD, as compared with disease-free individuals," said Dr. Shale. "However, unlike diabetes mellitus, the risk of premature excess cardiovascular disease in COPD is not appreciated."
At the beginning of the study, none of the participants had a history of heart disease or possessed cardiovascular symptoms. Of the 75 COPD patients studied, 18 had osteoporosis, while among the controls, only two individuals suffered from abnormal loss of bony tissue. Also, those who had osteoporosis of the hip had a greater aortic pulse wave velocity than those without the hip problem.
In an editorial on the study in the same issue of the journal, Claus Vogelmeier, M.D., and Robert Bals, M.D., of Philipps-University, Marburg in Germany, said that the study provides "important new information" on the relationship of cardiovascular disease and COPD.
They noted that aortic pulse wave velocity-considered the most clinically relevant measure of arterial stiffness-has been shown to predict cardiovascular outcome in various populations. The authors also highlighted the study's correlation of pulse wave velocity and COPD severity as important.
"The more severe the flow limitation, the higher the pulse wave velocity values," wrote Drs. Vogelmeier and Bals. "Thus, COPD may induce arterial stiffness, which in turn may promote vascular remodeling, thickening of arterial walls and plaque formation. The process may start in the early stages of COPD and worsen with the decline of lung function."
The editorialists also commented on osteoporosis, which was the second focus of the study: "The authors found that bone mineral density was lower in patients with COPD than in control subjects. Among the patients with COPD, 32 percent had osteoporosis and this was not restricted to those with severe COPD."
Although the editorialists termed the relationship between COPD and osteoporosis in the study was not "novel," they noted that those patients with osteoporosis also had the greatest arterial stiffness values-a new finding.
They concluded that future research is necessary to uncover further relationships between this study's findings and accelerated aging processes in COPD, which might then be avoided.
American Thoracic Society
COPD Current Events and COPD News RSSBeta-blockers reduce mortality in patients with COPD after vascular surgery
In the first study to directly examine the effects of beta-blockers on surgical patients with chronic obstructive pulmonary disease (COPD), researchers have found that, contrary to previous thought, beta-blockers significantly reduce mortality in COPD patients.
Common bronchodilator linked to increased deaths
A common bronchodilator drug which has been used for more than a decade by patients with chronic obstructive pulmonary disease (COPD) has been linked to a one-third higher risk of cardiovascular-related deaths.
COPD? Eat your veggies
You know it's good for you in other ways, but could eating your broccoli also help patients with chronic lung disease? It just might.
Key component of debilitating lung disease identified
For the first time, researchers have demonstrated a close correlation between the decline in a key component of the lung's antioxidant defense system and the progression of chronic obstructive pulmonary disease (COPD) in humans.
Creating lung cancer risk models for specific populations refines prediction
Lung cancer risk prediction models are enhanced by taking into account risk factors by race and by measuring DNA repair capacity, according to research teams led by epidemiologists at The University of Texas M. D. Anderson Cancer Center in two complementary papers appearing in the September issue of Cancer Prevention Research.
African-Americans have unique lung cancer risks from chronic obstructive pulmonary disease
Scientists at the M.D. Anderson Cancer Center have developed a risk prediction assessment for lung cancer specifically for African Americans that suggests a greater risk from chronic obstructive pulmonary disease (COPD).
Infection Blocks Lung's Protective Response Against Tobacco Smoke
An infection that often goes undetected can block the lung's natural protective response against tobacco smoke, according to researchers at National Jewish Health.
Hope for patients with COPD
For the first time, a drug therapy appears to reduce lung function loss in patients with moderate to severe chronic obstructive pulmonary disease (COPD), according to the results of a randomized, double-blind, placebo-controlled trial in 42 countries.
Yale study shows why cigarette smoke makes flu, other viral infections worse
A new study by researchers at Yale School of Medicine could explain why the cold and flu virus symptoms that are often mild and transient in non-smokers can seriously sicken smokers. Published in the Journal of Clinical Investigation, the study also identified the mechanism by which viruses and cigarette smoke interact to increase lung inflammation and damage.
Low-intensity case management cuts COPD-related hospital visits in half
A new study has found that patients with chronic obstructive pulmonary disease (COPD) who are at high risk for hospitalization or emergency room visits from exacerbations or complications benefit from simple low-intensity case management.
More COPD Current Events and COPD News Articles
 | COPD For Dummies (For Dummies (Health & Fitness)) by Kevin, MD Felner, Meg Schneider Make your home COPD friendly Your reassuring guide to understanding and managing COPD and getting on with your life Want to know more about COPD? This straightforward guide provides clear information about this progressive disease, explaining how to recognize the warning signs, get diagnosed, and choose the best treatment. You'll see how diet, exercise, and medication affect your... |
 | Natural Therapies for Emphysema and COPD: Relief and Healing for Chronic Pulmonary Disorders by Robert J. Green Jr. The first book to address emphysema and chronic obstructive pulmonary disease (COPD) from a nutritional and alternative medicine approach • Explains the benefits of detoxification, dietary changes, and food combining • Details 45 suggested herbs and 26 nutritional supplements as well as information on how to stop smoking Approximately 35 million people in the United States have been diagnosed... |
 | 100 Questions & Answers About COPD (100 Questions & Answers about . . .) by Campion E. Quinn Chronic Obstructive Pulmonary Disease, or COPD, is a disabling and potentially fatal illness affecting more than 13 million people and is the fifth leading cause of death in the United States. Whether you or a loved one has been diagnosed with COPD, the number and type of diagnosis and treatment options can be overwhelming. This invaluable resource offers the guidance and advice you need. Written... |
 | Asthma and COPD: Basic Mechanisms and Clinical Management by Peter Barnes, Jeffrey Drazen, Stephen Rennard, Neil C. Thomson Chronic obstructive pulmonary disease (COPD), which encompasses both chronic bronchitis and emphysema, is one of the most common respiratory conditions of adults in the developed world. Asthma and COPD: Basic Mechanisms and Clinical Management provides a unique, authoritative comparison of asthma and COPD. Written and edited by the world's leading experts, it is a comprehensive review of the most... |
 | Huffin' n' Puffin': Living with COPD by Leland Gordon Vogel Huffin' 'n Puffin': Living with COPD - provides practical information about living with COPD - the 3rd largest cause of disability and 4th largest killer disease. Written by a COPD patient, this book fills a void of practical information for COPD patients, families and caregivers everywhere. Using stories and poetry in a light-hearted manner, the author explains what COPD is, explores diagnosis,... |
 | Therapeutic Strategies in COPD Three diseases are involved in most cases of chronic obstructive pulmonary disease (COPD): emphysema, chronic bronchitis, and asthma. All of these diseases are growing in prevalence in the Western world, most likely as a consequence of increased environmental pollution and increased exposure to allergens. Reviewing current treatment options, Therapeutic Strategies in COPD helps doctors improve... |
 | Contemporary Diagnosis and Management of COPD |
 | Coping with COPD: Understanding, Treating, and Living with Chronic Obstructive Pulmonary Disease by Elaine Fantle Shimberg The first hands-on guide to living and coping with an insidious disease that affects tens of millions of peopleExperts estimate that as many as thirty-five million Americans literally cannot catch their breath-they are suffering from Chronic Obstructive Pulmonary Disease. The fourth-leading cause of death in America, COPD is a combination of chronic bronchitis and emphysema with airflow... |
 | Breathe Out: Living Life to the Fullest, with Emphysema, COPD, or Smoker's Lung by Mary Callahan RN BREATHE OUT THROUGH PURSED LIPS! Those words are golden for persons with chronic lung disease. Once mastered, the technique can help with everything from going up stairs to picking up a grandchild, all without shortness of breath. That advice and so many more practical tips for getting through the day and getting through life are contained in the pages of this book. Understanding how... |
 | ABC of COPD (ABC) Chronic obstructive pulmonary disease (COPD) is a common problem encountered in both primary and secondary care and contributes to a substantial workload for medical practitioners in district general hospitals, teaching hospitals (about 100f hospital admission) and the community. COPD treatment frequently involves a number of multidisciplinary team members; this series of articles would be of... |
| © 2008 BrightSurf.com |